""And yet, FDA approved PRR without any question. :)"
FDA approved a Phase2b/3 trial for Cvac. :)
Yondelis was involved in a phase3 trial in the US in which the FDA approved 4 years ago. The FDA rejected the drug in June 09 and the EMEA recently recommended the drug. DYOR
http://clinicaltrials.gov/ct2/show/NCT00113607?term=Yondelis&rank=4
As for investment funds buying into the stock. Investment funds back just as many losers as they do winners, that's why their returns are average.
PRR is currently in an uptrend if you hold enjoy the ride.
As for trading the stock while in an extended uptrend goodluck with that. Cheers
competition, page-13
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.005(1.27%) |
Mkt cap ! $581.0M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 41.0¢ | 38.5¢ | $1.351M | 3.389M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16911 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 154170 | 1 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |